Projects per year
Fingerprint
Dive into the research topics where Jonathan Brammer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Mechanisms of Resistance and Therapeutic Targets in T-LGL Leukemia
Brammer, J. (PI)
01/1/24 → 12/31/24
Project: Research
-
Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapies
Caputo, J., Peddireddi, A., Bhatta, S., Huang, Y., Bezerra, E., Brammer, J., Larkin, K., Mims, A., Vasu, S., Wall, S. & Choe, H., 2025, In: Leukemia and Lymphoma. 66, 1, p. 131-138 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome
Goyal, A., O'Leary, D., Dabaja, B., Weng, W. K., Zain, J., Cutler, C., Guitart, J., Kim, Y. H., Geskin, L. J., Hoppe, R. T., Wilson, L. D., Beaven, A. W., Horwitz, S., Allen, P. B., Barta, S. K., Bohjanen, K., Brammer, J. E., Carter, J. B., Comfere, N. & DeSimone, J. A. & 20 others, , Nov 2024, In: Transplantation and Cellular Therapy. 30, 11, p. 1047-1060 14 p.Research output: Contribution to journal › Article › peer-review
-
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma
Moustafa, M. A., Ramdial, J. L., Tsalatsanis, A., Khimani, F., Dholaria, B., Bojanini, L., Brooks, T., Zain, J., Bennani, N. N., Braunstein, Z., Brammer, J. E., Beitinjaneh, A., Jagadeesh, D., Weng, W. K., Kumar, A., Kharfan-Dabaja, M. A., Ahmed, S. & Murthy, H. S., May 2024, In: Transplantation and Cellular Therapy. 30, 5, p. 516.e1-516.e10Research output: Contribution to journal › Article › peer-review
Open Access -
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission
Shadman, M., Ahn, K. W., Kaur, M., Lekakis, L., Beitinjaneh, A., Iqbal, M., Ahmed, N., Hill, B., Hossain, N. M., Riedell, P., Gopal, A. K., Grover, N., Frigault, M., Brammer, J., Ghosh, N., Merryman, R., Lazaryan, A., Ram, R., Hertzberg, M. & Savani, B. & 10 others, , Dec 2024, In: Blood Cancer Journal. 14, 1, 108.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
Herrera, A. F., Zain, J., Savage, K. J., Feldman, T., Brammer, J. E., Chen, L., Puverel, S., Popplewell, L., Budde, L. E., Mei, M., Hosing, C., Nair, R., Leslie, L., Daniels, S., Peters, L., Forman, S., Rosen, S., Kwak, L. & Iyer, S. P., Sep 2024, In: The Lancet Haematology. 11, 9, p. e671-e681Research output: Contribution to journal › Article › peer-review
3 Scopus citations